37 filings
13F-HR
Foresite Capital Management V, LLC
15 May 24
Quarterly holdings report by institutional manager
12:29pm
4
KNTE
Kinnate Biopharma Inc
5 Apr 24
Change in insider ownership
2:15pm
13F-HR
Foresite Capital Management V, LLC
13 Feb 24
Quarterly holdings report by institutional manager
2:09pm
13F-HR
Foresite Capital Management V, LLC
13 Nov 23
Quarterly holdings report by institutional manager
4:44pm
4
FS Development Holdings II, LLC
31 Aug 23
PARDES BIOSCIENCES / James B. Tananbaum ownership change
5:22pm
13F-HR
305 bpyhw864pyu0
11 Aug 23
Quarterly holdings report by institutional manager
6:53am
4
ye6wcr6 c421
19 Jul 23
Theseus Pharmaceuticals / James B. Tananbaum ownership change
2:54pm
13F-HR
3cq5bp
12 May 23
Quarterly holdings report by institutional manager
9:19am
4
lrcgcvqvx
10 May 23
Change in insider ownership
5:42pm
4
1i855umlk0h7vk
6 Apr 23
PARDES BIOSCIENCES / James B. Tananbaum ownership change
9:08pm
4
2wpwnw78
22 Feb 23
Change in insider ownership
2:49pm
13F-HR
3hji9gxcrgfwz93qfa
13 Feb 23
Quarterly holdings report by institutional manager
4:50pm
4
rkp7ccht
3 Jan 23
Theseus Pharmaceuticals / James B. Tananbaum ownership change
4:24pm
4
n79mg1z0lk0 3h
5 Dec 22
PARDES BIOSCIENCES / James B. Tananbaum ownership change
4:24pm
13F-HR
2uypaaq
14 Nov 22
Quarterly holdings report by institutional manager
9:28am
13F-HR
y7ubr
12 Aug 22
Quarterly holdings report by institutional manager
9:29am
3
y8uja
13 Jun 22
Theseus Pharmaceuticals / James B. Tananbaum ownership change
5:15pm
4/A
7h4fherft n5
10 Jun 22
PARDES BIOSCIENCES / James B. Tananbaum ownership change
4:17pm
13F-HR
olbim
13 May 22
Quarterly holdings report by institutional manager
9:08am
13F-HR
dcp4eoa6 z5m
11 Feb 22
Quarterly holdings report by institutional manager
3:02pm